Baxter International | BAX - Cash And Equivalent

Stock Price
17.09
Daily Change
-0.53 -3.01%
Monthly
-19.92%
Yearly
-49.87%
Q1 Forecast
16.87

Baxter International reported $1.97B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Abbott USD 8.52B 1.01B Dec/2025
AngioDynamics USD 41.64M 14.26M Sep/2025
Artivion USD 64.91M 8.52M Dec/2025
AtriCure USD 167.43M 19.56M Dec/2025
Avanos Medical USD 89.8M 19.3M Dec/2025
Baxter International USD 1.97B 240M Dec/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Boston Scientific USD 1.96B 690M Dec/2025
Cooper Companies USD 110.6M 14.3M Sep/2025
Dexcom USD 917.7M 918M Dec/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Globus Medical USD 526.16M 154.39M Dec/2025
Halozyme Therapeutics USD 133.82M 285.84M Dec/2025
ICU Medical USD 307.96M 8.23M Dec/2025
Inogen USD 106.48M 2.79M Sep/2025
Insulet USD 716.1M 41.3M Dec/2025
Integra LifeSciences USD 235.05M 2.86M Dec/2025
Intuitive Surgical USD 9.03B 601.6M Dec/2025
J&J USD 19.71B 1.48B Dec/2025
Laboratory Of America USD 532.3M 65.8M Dec/2025
Masimo USD 312.3M 162.7M Sep/2025
Medtronic USD 1.28B 9M Sep/2025
Merit Medical Systems USD 446.4M 53.95M Dec/2025
Quest Diagnostics USD 420M 12M Dec/2025
Stryker USD 4.01B 755M Dec/2025
Tandem Diabetes Care USD 90.63M 1.31M Dec/2025
Teleflex USD 354M 100.3M Sep/2025
Terumo JPY 217.16B 12.86B Sep/2025
Zimmer Biomet Holdings USD 591.9M 700.8M Dec/2025